3 months ago
CAPR
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 13%
#652 out of 5184 analysts
Average Return
+40.76%
Win Rate
62%16 out of 26
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +267.46% | $5.87 | $21.57 | 2025-11-12 - 2026-01-28 | Strong Buy |
Capricor Therapeutics IncCAPR | +192.08% | $7.39 | $21.57 | 2025-07-14 - 2026-01-28 | Strong Buy |
Verona Pharma PLCVRNA | +136.53% | $45.20 | $106.91 | 2025-01-10 - 2025-10-07 | Strong Buy |
Cervomed IncCRVO | +128.81% | $2.36 | $5.40 | 2025-03-11 - 2026-01-28 | Strong Buy |
Gain Therapeutics IncGANX | +104.68% | $1.71 | $3.50 | 2024-12-04 - 2025-12-04 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
10 months ago
CRVO
a year ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ovid Therapeutics IncOVID | 1 | Strong Buy | $3.00 | +93.55% | Initiates Coverage On | 2 months ago |
Cingulate IncCING | 4 | Strong Buy | $16.00 | +170.73% | Maintains | 2 months ago |
Polypid LtdPYPD | 3 | Strong Buy | $9.00 | +90.68% | Maintains | 3 months ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $13.00 | -39.73% | Maintains | 3 months ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $62.00 | -14.44% | Initiates Coverage On | 4 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 2 | Strong Buy | $3.00 | +923.89% | Reiterates | 5 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $3.00 | +405.05% | Maintains | 5 months ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +206.12% | Maintains | 6 months ago |
Cervomed IncCRVO | 4 | Strong Buy | $16.00 | +196.30% | Reiterates | 6 months ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +8.50% | Reiterates | 7 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.